Roles Of Impaired Apoptosis And Differentiation In Tumourigenesis And Therapy
Funder
National Health and Medical Research Council
Funding Amount
$21,656,910.00
Summary
The ten scientific laboratories in this program have joined forces to investigate two ways in which tumours develop. Both are of particular interest, because they suggest new ways in which cancer might be overcome. Most of our tissues are continually renewed throughout life by production of new cells. Therefore many of the old cells in each tissue must die off to maintain the proper cell numbers. To eliminate cells that are no longer needed or have become damaged, the body has developed a remark ....The ten scientific laboratories in this program have joined forces to investigate two ways in which tumours develop. Both are of particular interest, because they suggest new ways in which cancer might be overcome. Most of our tissues are continually renewed throughout life by production of new cells. Therefore many of the old cells in each tissue must die off to maintain the proper cell numbers. To eliminate cells that are no longer needed or have become damaged, the body has developed a remarkable cell suicide process termed apoptosis. Unfortunately, however, occasionally a random accident to the genes in one of our cells prevents the machinery for apoptosis from being turned on. In that case, the cell will not die when it should and, by continually dividing, it may eventually give rise to a cancer. Since most cancer cells still retain most of the machinery for apoptosis, however, a drug that could switch on this natural cell death machinery would provide a promising new approach to cancer therapy. Identifying and developing such drugs is one major long-term goal of this program. The other focus of our program concerns stem cells. These are rare cells with the remarkable ability to generate an entire tissue. For example, one of our laboratories has identified stem cells that can generate all the cells in the breast. The almost unlimited regenerative capacity of stem cells has a built-in danger. If a stem cell acquires the ability to proliferate excessively, it can go on to form a tumour. Indeed, many cancer researchers now suspect that rare stem cells within a tumour cause its inexorable growth. If tumour growth is maintained by stem cells, it will be essential to develop new forms of therapy that target these rare cancer stem cells rather than merely the bulk of the tumour cells. This is another key long-term goal of our program.Read moreRead less
Discovery Early Career Researcher Award - Grant ID: DE150100538
Funder
Australian Research Council
Funding Amount
$342,000.00
Summary
Understanding the role of miRNAs in the biology of ageing muscle. Skeletal muscle is the largest organ in the body and plays a vital role in maintaining independent living and social interaction. As it ages, skeletal muscle loses its ability to build up new muscle proteins. However, the principles underlying the biology of skeletal muscle ageing are not well understood. MicroRNAs (MiRNAs) are essential regulators of skeletal muscle biology. Whether they play a role in the ageing process and how ....Understanding the role of miRNAs in the biology of ageing muscle. Skeletal muscle is the largest organ in the body and plays a vital role in maintaining independent living and social interaction. As it ages, skeletal muscle loses its ability to build up new muscle proteins. However, the principles underlying the biology of skeletal muscle ageing are not well understood. MicroRNAs (MiRNAs) are essential regulators of skeletal muscle biology. Whether they play a role in the ageing process and how they regulate muscle protein synthesis as we age has not been investigated. This project aims to identify the MiRNA species involved in muscle protein synthesis and will provide a better understanding of the biology of ageing skeletal muscle.Read moreRead less
Controlling apoptotic cell death in health and disease. Regulating how and when cells die is crucial for the development and maintenance of a healthy body and mind. This project will investigate the proteins that are responsible for controlling cell death with the view to identifying novel ways to target these proteins for the treatment of disorders such as cancer, neurodegenerative disease and autoimmunity.
Controlling apoptotic cell death in health and disease. Regulating how and when cells die is crucial for the development and maintenance of a healthy body and mind. This project will investigate the proteins that are responsible for controlling cell death with the view to identifying novel ways to target these proteins for the treatment of disorders such as cancer, neurodegenerative disease and autoimmunity.
A New Function For An Old Enzyme: Src Protein Kinase Directs Excitotoxic Neuronal Death In Stroke
Funder
National Health and Medical Research Council
Funding Amount
$513,975.00
Summary
In our previous investigation of how brain cells die in patients suffering from stroke, we found that stroke causes aberrant activation of an enzyme called Src in the affected brain cells. Furthermore, this aberrantly activated Src directs the brain cells to undergo cell death. Our proposal, which aims to decipher this neurotoxic mechanism of the aberrantly activated Src will benefit development of new therapeutic strategies to reduce brain damage in stroke patients.
Linkage Infrastructure, Equipment And Facilities - Grant ID: LE150100035
Funder
Australian Research Council
Funding Amount
$610,000.00
Summary
A single molecule real-time DNA sequencing facility. A single molecule real-time DNA sequencing facility: A PacBio SMRT sequencing facility will be established and used to accelerate ten specific research programs across a breadth of biological disciplines at two institutions. A specialised high throughput DNA sequencing technology called Single Molecule Real-Time (SMRT) sequencing developed by Pacific Biosciences (PacBio) is revolutionising biological research. SMRT sequencing allows researche ....A single molecule real-time DNA sequencing facility. A single molecule real-time DNA sequencing facility: A PacBio SMRT sequencing facility will be established and used to accelerate ten specific research programs across a breadth of biological disciplines at two institutions. A specialised high throughput DNA sequencing technology called Single Molecule Real-Time (SMRT) sequencing developed by Pacific Biosciences (PacBio) is revolutionising biological research. SMRT sequencing allows researchers to discover important information in DNA and RNA molecules that are missed by other modern DNA sequencing approaches. It is expected that this facility will also be a key infrastructure resource for the wider scientific community, helping to address fundamental questions in biology.Read moreRead less
Only recently has it emerged that our cells have a built-in backup mechanism that instructs cells to die in extreme cases, such as when viruses have hijacked a cell. A misfiring backup mechanism is thought to underlie a number of human diseases, including inflammatory disease. Our investigation will establish a starting point for the development of novel anti-inflammatory drugs.
Understanding How Bcl-2 Proteins Form The Apoptotic Pores That Kill Cells
Funder
National Health and Medical Research Council
Funding Amount
$893,614.00
Summary
Programmed cell death termed apoptosis is a process our bodies use to remove cells that are a threat to our health, e.g. cancer cells. The proteins that regulate cell death are attractive targets for therapeutics that have become resistant to this defence mechanism. This study will reveal how proteins from the Bcl-2 family regulate cell death at the molecular level. Understanding this process will inform the development of drugs aimed at regulating cell death in cancer and other diseases.
What Is The Molecular Mechanism Underlying Cell Death By Necroptosis?
Funder
National Health and Medical Research Council
Funding Amount
$653,742.00
Summary
Recently, we and others have demonstrated that part of the MLKL protein is able to kill cells. This process is known to cause a number of pathologies, including those arising from stroke. Blocking this type of cell death has thus emerged as an attractive therapeutic strategy. However, precisely how MLKL kills cells remains unclear and controversial. In this project, we will resolve these controversies with the goal of an increased fundamental understanding to aid drug discovery.
Comprehensive Assessment Of Genetic And Environmental Risk Factors For Melanoma: A Population-based Family Study
Funder
National Health and Medical Research Council
Funding Amount
$150,679.00
Summary
Excessive sunlight can cause melanoma, a serious type of skin cancer. However, there are other factors including a person's genetic make-up that are thought to put some people at higher risk. Many 'healthy' people have small changes in their genes that might make them more likely to develop melanoma. We need to know more about these genetic factors. Our study will investigate how particular small genetic changes influence a person's likelihood of developing melanoma.